3/22/2023  8:58:41 PM Chg. -0.080 Volume Bid9:59:30 PM Ask9:59:30 PM Market Capitalization Dividend Y. P/E Ratio
37.250EUR -0.21% 14,023
Turnover: 528,396.730
37.280Bid Size: 270 37.520Ask Size: 270 11.02 bill.EUR 3.59% 11.37

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.

Management board & Supervisory board

Carla Kriwet (ab 1.01.2023)
Management board
Helen Giza, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, William Valle
Supervisory board
Dr. Dieter Schenk, Dr. Dorothea Wenzel, Gregory Sorensen, MD, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 44.95%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49-6172-609-2601
IR Fax: -
IR e-mail: ir@fmc-ag.com

Company calendar

CW 19 | 5/9/2023 Interim Report 1st Quarter/3 Months
CW 20 | 5/16/2023 General Shareholder Meeting
CW 31 | 8/2/2023 Interim Report 2nd Quarter/6 Months
CW 44 | 11/2/2023 Interim Report 3rd Quarter/9 Months

Main Shareholders

Fresenius SE & Co. KGaA
Thornburg Investment Management Inc.
BlackRock, Inc.
Richard Pzena
Artisan Partners Asset Management Inc.
Harris Associates L.P.
FIL Limited
Norges Bank